Literature DB >> 11369161

Accuracy in equianalgesic dosing. conversion dilemmas.

R Anderson1, J H Saiers, S Abram, C Schlicht.   

Abstract

The clinical benefit and increased application of opioid rotation has focused attention on efficacy differences between opioids and their respective equianalgesic dose ratios. Understanding the differences between the opioids is critical to understanding their equianalgesic dose ratios and for adjusting therapy following rotation to a new analgesic. The purpose of this article is to describe controversies regarding the relative potencies of these agents as presented in current equianalgesic charts and to provide pharmacologic information to assist the clinician with opioid rotation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11369161     DOI: 10.1016/s0885-3924(01)00271-8

Source DB:  PubMed          Journal:  J Pain Symptom Manage        ISSN: 0885-3924            Impact factor:   3.612


  29 in total

1.  Clinical practice guidelines for the care and treatment of breast cancer: the management of chronic pain in patients with breast cancer (summary of the 2001 update).

Authors:  C Emery; R Gallagher; M Hugi; M Levine
Journal:  CMAJ       Date:  2001-10-30       Impact factor: 8.262

2.  Equianalgesic doses of opioids - their use in clinical practice.

Authors:  Douglas Natusch
Journal:  Br J Pain       Date:  2012-02

3.  Enhanced REVENUE After Surgery? A Cost-Standardized Enhanced Recovery Pathway for Mastectomy Decreases Length of Stay.

Authors:  Robert S Ackerman; Michael Hirschi; Brandon Alford; Trip Evans; John V Kiluk; Sephalie Y Patel
Journal:  World J Surg       Date:  2019-03       Impact factor: 3.352

Review 4.  Opioid Management in Older Adults with Chronic Kidney Disease: A Review.

Authors:  Montgomery T Owsiany; Chelsea E Hawley; Laura K Triantafylidis; Julie M Paik
Journal:  Am J Med       Date:  2019-07-08       Impact factor: 4.965

5.  Dose calculation in opioid rotation: electronic calculator vs. manual calculation.

Authors:  Herbert Plagge; Wilhelm Ruppen; Norman Ott; Thomas Fabbro; Delia Bornand; Stefanie Deuster
Journal:  Int J Clin Pharm       Date:  2011-01-13

6.  The subjective, reinforcing, and analgesic effects of oxycodone in patients with chronic, non-malignant pain who are maintained on sublingual buprenorphine/naloxone.

Authors:  Jermaine D Jones; Maria A Sullivan; Jeanne Manubay; Suzanne K Vosburg; Sandra D Comer
Journal:  Neuropsychopharmacology       Date:  2010-10-27       Impact factor: 7.853

7.  Opioid Use and Potency Are Associated With Clinical Features, Quality of Life, and Use of Resources in Patients With Gastroparesis.

Authors:  William L Hasler; Laura A Wilson; Linda A Nguyen; William J Snape; Thomas L Abell; Kenneth L Koch; Richard W McCallum; Pankaj J Pasricha; Irene Sarosiek; Gianrico Farrugia; Madhusudan Grover; Linda A Lee; Laura Miriel; James Tonascia; Frank A Hamilton; Henry P Parkman
Journal:  Clin Gastroenterol Hepatol       Date:  2018-10-13       Impact factor: 11.382

8.  Addition of a second opioid may improve opioid response in cancer pain: preliminary data.

Authors:  Sebastiano Mercadante; Patrizia Villari; Patrizia Ferrera; Alessandra Casuccio
Journal:  Support Care Cancer       Date:  2004-11       Impact factor: 3.603

9.  Early Patient Outcomes After Primary Total Knee Arthroplasty with Quadriceps-Sparing Subvastus and Medial Parapatellar Techniques: A Randomized, Double-Blind Clinical Trial.

Authors:  Ivan M Tomek; Stephen R Kantor; LuAnne A Cori; Jennifer M Scoville; Margaret R Grove; Tamara S Morgan; Ishaan Swarup; Wayne E Moschetti; Kevin F Spratt
Journal:  J Bone Joint Surg Am       Date:  2014-06-04       Impact factor: 5.284

Review 10.  The American Society of Pain and Neuroscience (ASPN) Best Practices and Guidelines for the Interventional Management of Cancer-Associated Pain.

Authors:  Mansoor M Aman; Ammar Mahmoud; Timothy Deer; Dawood Sayed; Jonathan M Hagedorn; Shane E Brogan; Vinita Singh; Amitabh Gulati; Natalie Strand; Jacqueline Weisbein; Johnathan H Goree; Fangfang Xing; Ali Valimahomed; Daniel J Pak; Antonios El Helou; Priyanka Ghosh; Krishna Shah; Vishal Patel; Alexander Escobar; Keith Schmidt; Jay Shah; Vishal Varshney; William Rosenberg; Sanjeet Narang
Journal:  J Pain Res       Date:  2021-07-16       Impact factor: 3.133

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.